Intuitive Surgical (NASDAQ:ISRG) Reports Strong Fourth Quarter Results for Fiscal Year 2025

Intuitive Surgical Surpasses Q4 2025 Expectations

Intuitive Surgical (NASDAQ:ISRG), a leader in medical technology, delivered fourth-quarter 2025 results that exceeded market forecasts. The company posted revenue of $2.87 billion, marking an 18.8% increase compared to the same period last year. Adjusted earnings per share reached $2.53, outperforming analyst predictions by 11.6%.

Considering these results, is Intuitive Surgical a smart investment right now?

Q4 2025 Performance Highlights

• Revenue: $2.87 billion, surpassing the $2.74 billion consensus (18.8% year-over-year growth, 4.6% above estimates)
• Adjusted EPS: $2.53, beating the $2.27 forecast (11.6% above estimates)
• Adjusted EBITDA: $1.07 billion, below the $1.15 billion estimate (37.4% margin, 6.8% shortfall)
• Operating Margin: 30.2%, consistent with the prior year’s quarter
• Market Cap: $185.6 billion

About Intuitive Surgical

Since the FDA approved its first da Vinci system in 2000, Intuitive Surgical has been at the forefront of minimally invasive surgery. The company designs and produces robotic-assisted surgical platforms used in a wide range of medical fields, enabling less invasive procedures for patients worldwide.

Examining Revenue Growth

Sustained revenue expansion is a hallmark of a high-quality business. While many companies can achieve short-term gains, only a select few maintain strong growth over time. Intuitive Surgical has demonstrated impressive momentum, with annualized revenue growth of 18.2% over the past five years—outpacing the healthcare sector average and signaling strong demand for its products.

Intuitive Surgical Quarterly Revenue

While long-term trends are crucial, recent performance can reveal shifts in innovation or market demand. Over the last two years, the company’s annualized revenue growth rate was 18.9%, closely matching its five-year average and indicating steady, robust demand.

Intuitive Surgical Year-On-Year Revenue Growth

For the most recent quarter, revenue climbed 18.8% year-over-year, with the $2.87 billion figure topping Wall Street’s projections by 4.6%.

Looking forward, analysts anticipate revenue will rise by 12.8% over the coming year—a slower pace than recent years, but still a strong outlook given the company’s scale and market position.

Microsoft, Alphabet, Coca-Cola, and Monster Beverage all started as lesser-known growth stories before becoming industry leaders. We believe we’ve identified the next major opportunity: a profitable AI semiconductor company that remains underappreciated by Wall Street.

Profitability and Operating Margins

Operating margin is a key indicator of profitability, reflecting how much profit remains after accounting for essential expenses such as marketing and research and development.

Over the past five years, Intuitive Surgical has operated efficiently, maintaining an average operating margin of 27.9%, placing it among the more profitable healthcare companies.

Although its operating margin has declined by 2.6 percentage points over five years, it has improved by 4.5 points in the last two years. We remain optimistic about the company’s ability to maintain or improve its profitability.

Intuitive Surgical Trailing 12-Month Operating Margin (GAAP)

In the fourth quarter, the company achieved an operating margin of 30.2%, matching the result from the same period a year ago. This consistency suggests a stable cost structure.

Earnings Per Share (EPS) Trends

While revenue growth highlights expansion, long-term changes in earnings per share (EPS) reveal how profitable that growth has been. Sometimes, companies can boost sales through heavy spending, which may not translate into higher profits.

Intuitive Surgical’s EPS has grown at a remarkable 21.6% compound annual rate over the past five years, outpacing its revenue growth. However, since operating margins remained flat and there were no share buybacks, this improvement likely resulted from lower interest or tax expenses.

Intuitive Surgical Trailing 12-Month EPS (Non-GAAP)

For Q4, adjusted EPS reached $2.53, up from $2.21 a year earlier—comfortably beating analyst expectations. Looking ahead, Wall Street projects full-year EPS of $8.93, representing an 8.5% increase over the next year.

Summary of Q4 Results

Intuitive Surgical’s latest quarter was marked by strong revenue and EPS beats, which were well received by investors. Following the announcement, shares rose 1.1% to $531.88.

While the recent quarter was impressive, it’s important to consider the company’s long-term fundamentals and valuation when evaluating its investment potential.